| Date | Title | | | 06/11/13 | OvaScience Appoints Mary Fisher to Company’s Board of Directors| CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jun. 11, 2013--
OvaScienceSM,
(NASDAQ: OVAS), a life sciences company focused on the discovery,
development and commercialization of new treatments for infertility,
announced today the appointment of Mary Fisher, President and Chief
Executive Officer of Colorescience, to its Board of Directors.
“Mary understands how to commercialize consumer health care products,
and we are fortunate to have her join our ... |
|  | | 06/04/13 | OvaScience Co-Founders’ Review of Female Infertility Published in Cell Metabolism| -- Findings Highlight that Egg Quality Decreases With Age Due to
Reduced Mitochondrial Function --
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jun. 4, 2013--
OvaScienceSM,
(NASDAQ: OVAS), a life sciences company focused on the discovery,
development and commercialization of new treatments for infertility,
announced today the publication of an in-depth review article regarding
female infertility due to aging and poor egg quality. The article is
a... |
| | | 06/03/13 | OvaScience Chief Executive Officer Selected Entrepreneur of The Year 2013 Finalist for New England by Ernst & Young| CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jun. 3, 2013--
OvaScienceSM,
(NASDAQ: OVAS), a life sciences company focused on the discovery,
development and commercialization of new treatments for infertility,
announced today that Michelle Dipp, M.D., Ph.D., fertility advocate,
co-founder and Chief Executive Officer, has been selected as a finalist
for the Ernst & Young Entrepreneur Of The Year® 2013
Awards in New England. Finalists were chosen by a pane... |
| | | 05/29/13 | OvaScience to Present at Jefferies 2013 Global Healthcare Conference| CAMBRIDGE, Mass.--(BUSINESS WIRE)--May. 29, 2013--
OvaScienceSM,
(NASDAQ: OVAS), a life sciences company focused on the discovery,
development and commercialization of new treatments for infertility,
today announced that Michelle Dipp, M.D., Ph.D., Chief Executive Officer
of OvaScience, will present at the Jefferies 2013 Global Healthcare
Conference on Tuesday, June 4 at 9 a.m. in New York City.
A live audio webcast of the presentation can... |
| |
|
